CZ277870B6 - Preparation containing gestoden for transdermal application - Google Patents

Preparation containing gestoden for transdermal application Download PDF

Info

Publication number
CZ277870B6
CZ277870B6 CS896089A CS608989A CZ277870B6 CZ 277870 B6 CZ277870 B6 CZ 277870B6 CS 896089 A CS896089 A CS 896089A CS 608989 A CS608989 A CS 608989A CZ 277870 B6 CZ277870 B6 CZ 277870B6
Authority
CZ
Czechia
Prior art keywords
layer
skin
optionally
gestodene
estrogen
Prior art date
Application number
CS896089A
Other languages
Czech (cs)
English (en)
Inventor
Clemens Gunther
Ulrich Dr Tauber
Karin Dr Schmidt-Gollwitzer
Jutta Dr Riedl
Johannes Wilhelm Dr Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CZ608989A3 publication Critical patent/CZ608989A3/cs
Publication of CZ277870B6 publication Critical patent/CZ277870B6/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CS896089A 1989-03-29 1989-10-27 Preparation containing gestoden for transdermal application CZ277870B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19893910578 DE3910578A1 (de) 1989-03-29 1989-03-29 Mittel zur transdermalen applikation enthaltend gestoden

Publications (2)

Publication Number Publication Date
CZ608989A3 CZ608989A3 (en) 1993-02-17
CZ277870B6 true CZ277870B6 (en) 1993-06-16

Family

ID=6377622

Family Applications (1)

Application Number Title Priority Date Filing Date
CS896089A CZ277870B6 (en) 1989-03-29 1989-10-27 Preparation containing gestoden for transdermal application

Country Status (5)

Country Link
CZ (1) CZ277870B6 (pl)
DE (1) DE3910578A1 (pl)
PL (2) PL162410B1 (pl)
RU (1) RU2044541C1 (pl)
SK (1) SK608989A3 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018774A1 (de) * 1992-03-21 1993-09-30 Entec Gesellschaft Für Endokrinologische Technologie M.B.H. Verwendung von östriol zur behandlung von klimakterischer osteoporose
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
CN1195505C (zh) 1999-07-02 2005-04-06 Lts勒曼治疗***股份公司 以聚硅氧烷及亲两性溶剂为基础的微贮存***
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
WO2008136699A1 (fr) * 2007-05-04 2008-11-13 Igor Alexandrovich Bazikov Patch transdermique à microcapsules et procédé de fabrication correspondant

Also Published As

Publication number Publication date
PL282033A1 (en) 1991-03-11
PL162410B1 (pl) 1993-11-30
DE3910578A1 (de) 1990-10-04
SK278438B6 (en) 1997-05-07
PL287526A1 (en) 1991-10-21
RU2044541C1 (ru) 1995-09-27
SK608989A3 (en) 1997-05-07
PL162400B1 (pl) 1993-11-30
CZ608989A3 (en) 1993-02-17

Similar Documents

Publication Publication Date Title
JP3238389B2 (ja) ゲストデン含有の経皮適用のための薬剤
KR100392435B1 (ko) 성스테로이드를함유하는경피치료시스템
US5858394A (en) Agent for transdermal administration that contains gestodene esters
JPH08500584A (ja) 3−ケト−デソゲストレルを含有する経皮適用剤
CZ277870B6 (en) Preparation containing gestoden for transdermal application
JPH09508911A (ja) デソゲストレルを含有する経皮適用剤
CA2699632A1 (en) Transdermal hormone spray
JPH11509222A (ja) 13−エチル−17β−ヒドロキシ−11−メチレン−18,19−ジノル−17α−プレグン−4−エン−20−イン−3−オンのエステルを含む経皮投与のための剤
JPH04505333A (ja) ロリプラムを含有する皮膚浸透移行性適用剤
JPH09510697A (ja) 14α,17α−エタノエストラ−1,3,5(10)−トリエン−3,17β−ジオールを含有する経皮投与のための薬剤
AU724308B2 (en) Transdermal therapeutic systems that contain sex steroids
HUT74616A (en) Agent, intended for transdermal administration, containing 14alfa, 17alfa-ethanoestra-1,3,5(10)-triene-3,17beta-diol
CA2182188A1 (en) Agent, intended for transdermal administration, containing 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20091027